tazarotene has been researched along with Colorectal Cancer in 1 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metastatic colorectal cancer patients preparing to initiate cetuximab were randomly assigned to receive daily oral minocycline or placebo, and to receive topical tazarotene application to either left or right side of the face." | 5.12 | Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. ( Agero, AL; Dusza, SW; Halpern, AC; Kemeny, NE; Lieb, JA; Myskowski, PL; Saltz, L; Scope, A, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scope, A | 1 |
| Agero, AL | 1 |
| Dusza, SW | 1 |
| Myskowski, PL | 1 |
| Lieb, JA | 1 |
| Saltz, L | 1 |
| Kemeny, NE | 1 |
| Halpern, AC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Aprepitant vs. Desloratadine in Non-small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Related Pruritus: A Prospective, Randomized Control, Double-blinded, Phase II Clinical Trial[NCT02646020] | Phase 2 | 138 participants (Actual) | Interventional | 2015-12-31 | Completed | ||
| A Randomized Control Trial to Compare Doxycycline to Isotretinoin for the Treatment of Acneiform Eruptions in Cancer Patients on Tyrosine Kinase Inhibitors[NCT04864717] | Phase 4 | 98 participants (Anticipated) | Interventional | 2021-09-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for tazarotene and Colorectal Cancer
| Article | Year |
|---|---|
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.
Topics: Acneiform Eruptions; Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; | 2007 |
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.
Topics: Acneiform Eruptions; Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; | 2007 |
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.
Topics: Acneiform Eruptions; Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; | 2007 |
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.
Topics: Acneiform Eruptions; Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; | 2007 |